Portal Vein Thrombosis after C-Section in a Patient with Polycythemia Vera (PV) Due to Pregnancy and Iron Deficiency Anemia (IDA)
Authors:
- Thomas NtounisTNThomas Ntounis
- Konstantinos A. ZioutosKZKonstantinos A. Zioutos
- Antonios KoutrasAKAntonios Koutras
- Ioannis ProkopakisIPIoannis Prokopakis
- Zacharias FasoulakisZFZacharias Fasoulakis
- Ioakeim SapantzoglouISIoakeim Sapantzoglou
- Paraskevas PerrosPPParaskevas Perros
- Athina A. SamaraAthina A. Samara
- Emmanouil SpanoudakisESEmmanouil Spanoudakis
- Asimina ValsamakiAVAsimina Valsamaki
- Sevasti-Effraimia KrouskouSKSevasti-Effraimia Krouskou
- Konstantinos NikolettosKNKonstantinos Nikolettos
Open Access
- 14 December 2022
- journal article
- case report
- Published by MDPI AG in Clinics and Practice
- Vol. 12 (6) , 1069-1077
Abstract
Polycythemia vera (PV) is one of the three main classic disorders of Philadelphia-negative myeloproliferative neoplasms (MPNs), with the other two being essential thrombocythemia (ET) and primary myelofibrosis (PMF). PV may develop (15%) in women of childbearing age (15–45 years), with an anticipated rate of roughly 0.3 per 100,000 people, although maintaining a male to female ratio predominance of about 2:1 and a peak prevalence in the sixth and seventh decades of life. Without always being presented with its actual clinical manifestations due to pregnancy itself, and most commonly due to iron deficiency, PV can be frequently missed and therefore belatedly diagnosed. We describe the case of a primipara woman in her 40s, without risk factors for thrombosis, who developed a portal vein occlusion 1.5 month postpartum after C-section and who had a delayed diagnosis of PV.Keywords
This publication has 10 references indexed in Scilit:
- Polycythemia vera in pregnancy represents a challenge for a multidisciplinary collaboration: A case report and literature reviewExperimental and Therapeutic Medicine, 2021
- A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosisBritish Journal of Haematology, 2018
- Contemporary management of patients with BCR-ABL1-negative myeloproliferative neoplasms during pregnancyExpert Review of Hematology, 2018
- The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussionBlood Cancer Journal, 2018
- Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort studyBritish Journal of Haematology, 2016
- Philadelphia Chromosome–Negative Myeloproliferative Disorders: Biology and TreatmentTransplantation and Cellular Therapy, 2007
- Essential Thrombocythemia/Polycythemia Vera and Pregnancy: The Need for an Observational Study in EuropeSeminars in Thrombosis and Hemostasis, 2006
- Myeloproliferative Disease in Pregnancy and Other Management IssuesHematology-American Society Hematology Education Program, 2006
- Pregnancy and its management in the Philadelphia negative myeloproliferative diseasesBritish Journal of Haematology, 2005
- Polycythemia rubra vera and pregnancy.1983